| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | 1 | — | — | — | — |
| Sell | 1 | — | 9 | 2 | — | 1 | — | — | 3 | — | 1 | 1 |
| total | individual payouts | |
|---|---|---|
| 2029 | ‡‡‡‡‡ |
|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 4.98 |
—
—
—
—
|
| 2025 | 4.32 |
—
—
—
—
|
| 2024 | 3.74 |
—
—
—
—
|
| 2023 | 3.24 |
—
—
—
—
|
| 2022 | 2.82 |
—
—
—
—
|
| 2021 | 2.45 |
—
—
—
—
|
| 2020 | 2.18 |
—
—
—
—
|
| 2019 | 1.94 |
—
—
—
—
|
| 2018 | 1.64 |
—
—
—
—
|
| 2017 | 1.41 |
—
—
—
—
|
| 2016 | 1.24 |
—
—
—
—
|
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Cash | 3,662.00 | 4,074.00 | 4,552.00 | 7,200.00 |
| Receivables | 434.00 | 535.00 | 580.00 | 749.00 |
| Inventory | — | — | — | — |
| Other | 420.00 | 3,921.00 | 7,076.00 | 5,038.00 |
| 5,557.00 | 9,678.00 | 14,107.00 | 15,311.00 |
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Payables | 638.00 | 721.00 | 792.00 | 873.00 |
| ST’ Debt | 89.00 | — | — | — |
| Other | 868.00 | 4,478.00 | 7,701.00 | 5,901.00 |
| 3,790.00 | 7,491.00 | 10,370.00 | 10,163.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Oct | Jan | Apr | Jul | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 3,885.00 | 4,651.00 | 8,558.00 | 4,354.00 |
21,448.00
|
| ’25 | 3,283.00 | 3,963.00 | 7,754.00 | 3,831.00 |
18,831.00
|
| ’24 | 2,978.00 | 3,386.00 | 6,737.00 | 3,184.00 |
16,285.00
|
| ’23 | 2,597.00 | 3,041.00 | 6,018.00 | 2,712.00 |
14,368.00
|
| ’22 | 2,007.00 | 2,673.00 | 5,632.00 | 2,414.00 |
12,726.00
|
| ’21 | 1,323.00 | 1,576.00 | 4,173.00 | 2,561.00 |
9,633.00
|
| Oct | Jan | Apr | Jul | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 637.00 | 1,570.00 | 5,300.00 | 1,331.00 |
8,838.00
|
| ’25 | 362.00 | 1,069.00 | 4,395.00 | 381.00 |
6,207.00
|
| ’24 | (97.00) | 613.00 | 3,951.00 | 417.00 |
4,884.00
|
| ’23 | 328.00 | 284.00 | 3,592.00 | 842.00 |
5,046.00
|
| ’22 | 145.00 | 85.00 | 3,320.00 | 339.00 |
3,889.00
|
| ’21 | 45.00 | 279.00 | 2,384.00 | 542.00 |
3,250.00
|
| Oct | Jan | Apr | Jul | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 599.00 | 1,524.00 | 5,236.00 | 1,258.00 |
8,617.00
|
| ’25 | 329.00 | 1,038.00 | 4,360.00 | 356.00 |
6,083.00
|
| ’24 | (181.00) | 550.00 | 3,890.00 | 375.00 |
4,634.00
|
| ’23 | 251.00 | 229.00 | 3,504.00 | 802.00 |
4,786.00
|
| ’22 | 103.00 | 20.00 | 3,259.00 | 278.00 |
3,660.00
|
| ’21 | 7.00 | 246.00 | 2,354.00 | 518.00 |
3,125.00
|
| Oct | Jan | Apr | Jul | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 1.59 | 2.48 | 11.09 | 1.34 |
16.46
|
| ’25 | 0.70 | 1.67 | 10.02 | 1.35 |
13.67
|
| ’24 | 0.85 | 1.25 | 8.42 | (0.07) |
10.43
|
| ’23 | 0.14 | 0.60 | 7.38 | 0.32 |
8.42
|
| ’22 | 0.82 | 0.35 | 6.28 | (0.20) |
7.28
|
| ’21 | 0.75 | 0.07 | 5.30 | 1.37 |
7.56
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 339.36 | 370.62 | 557.29 | 532.65 | 252.84 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 645.61 | 631.07 | 714.78 | 813.70 | 661.99 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17,300 | 18,200 | 18,800 | 18,200 | 18,600 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.74 | 0.79 | 0.87 | 1.03 | 1.15 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12,726.00 | 14,368.00 | 16,285.00 | 18,831.00 | 21,448.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 81.09% | 78.13% | 78.72% | 79.57% | 80.17% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,542.00 | 2,989.00 | 3,550.00 | 4,834.00 | 6,017.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.97% | 20.80% | 21.80% | 25.67% | 28.05% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,066.00 | 2,384.00 | 2,963.00 | 3,869.00 | 4,566.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 746.00 | 806.00 | 789.00 | 809.00 | 846.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 45.45 | 51.13 | 58.16 | 67.25 | 77.71 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 7.38 | 8.49 | 10.58 | 13.82 | 16.53 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.89 | 17.96 | 17.44 | 22.17 | 32.02 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.82) | (0.93) | (0.89) | (0.44) | (0.80) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.07 | 17.03 | 16.55 | 21.73 | 31.22 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 58.72 | 61.46 | 65.84 | 70.39 | 68.81 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 280.00 | 281.00 | 280.00 | 280.00 | 276.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 61.10 | 60.20 | 61.19 | 56.77 | 19.12 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.87 | 10.01 | 11.13 | 11.67 | 4.07 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.64 | 8.33 | 9.83 | 11.15 | 4.59 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.16 | 10.18 | 11.23 | 11.75 | 4.03 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35.32 | 30.58 | 39.45 | 36.39 | 10.04 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,889.00 | 5,046.00 | 4,884.00 | 6,207.00 | 8,838.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (229.00) | (260.00) | (250.00) | (124.00) | (221.00) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,660.00 | 4,786.00 | 4,634.00 | 6,083.00 | 8,617.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,417.00 | 1,767.00 | 2,187.00 | 3,737.00 | 5,148.00 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,998.00 | 6,209.00 | 5,539.00 | 5,973.00 | 6,420.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,717.00 | 2,547.00 | 1,465.00 | 1,421.00 | (780.00) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16,441.00 | 17,269.00 | 18,436.00 | 19,710.00 | 18,992.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.55% | 8.59% | 9.89% | 11.20% | 12.38% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.97% | 9.91% | 11.40% | 14.56% | 20.19% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.71% | 14.14% | 16.60% | 20.29% | 23.60% | — | — | — |
ROE
|
Intuit Inc. (INTU) has evolved into a dominant financial management platform, propelled by acquisitions like Credit Karma and Mailchimp, driving revenue from $4.69 billion in 2016 to $16.29 billion in 2024—a 21% CAGR—with projections reaching $26.90 billion by 2028. Subscription models in QuickBooks and TurboTax fuel scalability, evidenced by soaring revenue per employee, stable 78-80% gross margins, and robust free cash flow per share up 362%. Earnings per share have surged 184%, supported by a pristine balance sheet featuring low net debt and ROE above 16%, positioning Intuit for AI-driven expansion amid SMB digitalization.
Despite stellar fundamentals, the stock trades 44% below 2024 highs, at discounted valuations (PE 61x, EV/FCF 39x) versus historical peaks, amid macro caution like softening consumer spending and high rates. Insider selling ($628 million, no buys) under 10b5-1 plans tempers optimism, yet analysts forecast 50-143% upside, tied to 30%+ EPS CAGR and catalysts like generative AI in tax prep and Fed rate cuts boosting SMB lending.
In a high-tax-complexity U.S. environment, Intuit benefits from inflation-fueled payroll demand and geopolitical insulation, outperforming fintech peers. Risks include recessions hitting 70% SMB exposure or tax code simplification, but execution on 14% revenue CAGR could spark ROE rebound to 20%+ and significant re-rating—making current weakness a potential entry point.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.